Resibufogenine, a naturally occurring bioactive compound extracted from toad venom, has been shown to inhibit the growth and metastasis of colon cancer via triggering RIPK3/MLKL-dependent necroptosis in both in vitro and in vivo colon cancer models [265]. Here, RIPK3 is linked to colonic neoplasm.